Effects of Exergaming to Reduce Sedentary Time in Inactive Patients With Heart Failure
Launched by LINKOEPING UNIVERSITY · Dec 6, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a fun and interactive way to exercise, called exergaming, can help inactive patients with heart failure spend less time sitting and improve their overall health. The goal is to see if this type of exercise can lead to better daily activity, increased physical fitness, and a higher quality of life for these patients. Participants will either receive standard advice for physical activity or take part in the Heart-Exergame program, which offers personalized exercise recommendations and allows them to play with friends or family members.
To be eligible for the study, participants must be adults over 18 years old with a diagnosed heart failure condition, be willing to use a smartphone for the program, and be physically inactive. However, individuals with severe vision or hearing problems, those unable to walk a short distance, or anyone currently in a rehabilitation program will not be included. If selected, participants will engage in the program for three months, receiving support and feedback to help them stay active in a way that suits their needs.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosed with symptomatic HF (NYHA II-IV) as diagnosed by cardiologist, (independent of Ejection Fraction: Patients with a preserved ejection fraction (HFpEF), mid-range ejection fraction (HFmrREF) or reduced ejection fraction (HFrEF) can be included.
- • 2. Clinically stable
- • 3. Physically inactive
- • 4. Older than 18 years, there is no upper age limit,
- • 5. Speak/understand the language of the country where the study is taking place.
- • 6. Wanting to use a smartphone for the study (if patients do not have a smartphone, they can borrow it from the study team for the duration of the study)
- Exclusion Criteria:
- • 1. Unable to use an exergame due to visual, hearing, cognitive impairment assessed by HF nurse or cardiologist.
- • 2. Not being able to perform the 6-minute walk test.
- • 3. Not being able or willing to wear an activity monitor.
- • 4. Currently included in a rehabilitation program
- • 5. Lack of willingness to play an exergame.
- • 6. Co-morbidity that hinders benefitting for this form of exercise (history of stroke, severe cognitive dysfunction, or a life expectancy shorter than 6 months).
Trial Officials
Tiny Jaarsma, PhD
Principal Investigator
Linkoeping University
About Linkoeping University
Linköping University is a leading academic institution in Sweden, renowned for its innovative research and commitment to advancing medical science. With a strong emphasis on interdisciplinary collaboration, the university facilitates cutting-edge clinical trials aimed at improving patient outcomes and enhancing healthcare delivery. Linköping University’s research initiatives are supported by state-of-the-art facilities and a robust network of partnerships with healthcare providers, industry stakeholders, and regulatory bodies, ensuring rigorous methodologies and ethical standards in all clinical investigations. Through its dedication to research excellence, Linköping University plays a pivotal role in translating scientific discoveries into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
Linköping, , Sweden
Barcelona, , Spain
Barcelona, , Spain
Kalmar, , Sweden
Manresa, , Spain
Jönköping, , Sweden
Norrköping, , Slovakia
Valencia, , Spain
Norrköping, , Sweden
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials